Genetic predisposition to radiation induced sarcoma: Possible role for BRCA and p53 mutations

Breast Cancer Research and Treatment

Volumn 140, Issue 1, 2013, Pages 207-211

  Kadouri, Luna ^a   Sagi, Michal ^a   Goldberg, Yael ^a   Lerer, Israela ^a   Hamburger, Tamar ^a   Peretz, Tamar ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

BRCA1; BRCA2; p53; Radiation associated sarcoma

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; PROTEIN P53; TAMOXIFEN;

ADULT; ANGIOSARCOMA; ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER RADIOTHERAPY; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC PREDISPOSITION; GENETIC RISK; GROUPS BY AGE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; PARTIAL MASTECTOMY; PATIENT REFERRAL; PRIORITY JOURNAL; RADIATION INDUCED NEOPLASM; RADIATION INDUCED SARCOMA; THORAX WALL TUMOR;

ADULT; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; GENES, P53; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HUMANS; MIDDLE AGED; MUTATION; NEOPLASMS, RADIATION-INDUCED; RADIOTHERAPY; SARCOMA;

EID: 84880317372     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-013-2621-z     Document Type: Article

References (12)

1. Patel SR (2000) Radiation-induced sarcoma. Curr Treat Options oncol 1:258-261
2. Henderson TO, Whitton J, Stovall M, Mertens AC, Mitby P, Friedman D, Strong LC, Hammond S, Neglia JP, Meadows AT, Robison L, Diller L (2007) Secondary sarcoma in childhood cancer survivor study. J Natl Cancer Inst 99(4):300-308 (Pubitemid 47073493)
3. Hudson MM, Mulroney DA, Bowers DC, Sklar CA, Green DM, Donaldson SS, Oeffinger KC, Neglia JP, Meadows AT, Robison LL (2009) High-risk populations identified in childhood cancer survivor study investigations: implications for risk-based surveillance. J Clin Oncol 27(14):2405-2414
4. Gonin-Laurent N, Hadj-Hamou NS, Vogt N, Houdayer C, Gauthiers-Villars M, Dehainault C, Sastre-Garau X, Chevillard S, Malfoy B (2007) RB1 and TP53 pathways in radiation-induced sarcomas. Oncogene 26(41):6106-6112 (Pubitemid 47373799)
5. Mertens F, Larramendy M, Gustavsson A, Gisselsson D, Rydholm A, Brosjo O, Mitelman F, Knuutila S, Mandahl N (2000) Radiation-associated sarcomas are characterized by complex karyotypes with frequent rearrangements of chromosome are 3p. Cancer Genet Cytogenet 116(2):89-96
6. Guo T, Zhang L, Chang N, Singer S, Maki RG, Antonescu CR (2011) Consistent MYC and FLT4 gene amplification in radiation-induced angiosarcoma but not other radiation-associatieted atypical vascular lesions. Genes Chromosom Cancer 50:25-33
7. West JG, Weitzel JN, Tao ML, Carpenter M, West JE, Fanning C (2008) BRCA mutations and the risk of angiosarcoma after breast cancer treatment. Clin Breast Cancer 8(6):533-537
8. de Bree E, van Coevorden F, Peterse JL, Russell NS, Rutgers EJT (2002) Bilateral angiosarcoma of the breast after conservative treatment of bilateral invasive carcinoma: genetic predisposition? Eur J Surg Oncol 28:392-395
9. Salmon A, Amikam D, Sodha N, Davidson S, Basel-Vanagaite L, Eeles RA, Abeliovich D, Peretz T (2007) Rapid development of post-radiotherapy sarcoma and breast cancer in a patient with a novel germline 'de novo' TP53 mutation. Clin Oncol (R Coll Radiol) 19(7):490-493 (Pubitemid 47181183)
10. Kirova YM, Vilcoq JR, Asselain B, Sastre-Garau X, Fourquet A (2005) Radiation-induced sarcomas after radiotherapy for breast carcinoma. Cancer 104(4):856-863 (Pubitemid 41113688)
11. Pierce LJ, Phillips K, Griffith KG, Buys S, Gaffney DK, Moran MS, Haffty BG, Ben-David M, Kauffman B, Garber JE, Merajver SD, Balmana J, Meirovich A, Domchek SM (2010) Local therapy in BRCA1 and BRCA2 mutation carriers with operable breast cancer: comparison of breast conservation and mastectomy. Breast Cancer Res Treat 121:389-398
12. Andrieu N, Easton DF, Chang-Cloude J, Rookus MA, Brohet R, Cardis E, Antoniou AC, Wagner T, Simard J, Evans G, Peock S, Fricker J, Nogues C, V'ant Veer L, Van Leeuwen FE, Goldgar DE (2006) Effect of chest x-rays on the risk of breast cancer among BRCA1/2 mutation carriers in the international BRCA1/2 carrier cohort study: a report from EMBRACE, GENEPSO, GEO-HEBON, and IBCCS collaborators' group. J Clin Oncol 24(21):3361-3366 (Pubitemid 46638890)